Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Gliptin Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Gliptin Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Gliptin Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Gliptin Market-Segmentation by Type
5.1 Sitagliptin (Januvia)
5.2 Vildagliptin (Galvus)
5.3 Saxagliptin (Onglyza)
5.4 Linagliptin (Tradjenta)
5.5 Alogliptin (Vipidia/Nesina)
5.6 Other Types
6 Global Gliptin Market-Segmentation by Application
6.1 Type 2 Diabetes
6.2 OtherDiseases
7 Global Gliptin Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 Merck & Co., Inc.
8.1.1 Merck & Co., Inc. Profile
8.1.2 Merck & Co., Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Merck & Co., Inc. Product/Solution Launches and Enhancements Analysis
8.1.4 Merck & Co., Inc. Business Overview/Recent Development/Acquisitions
8.2 LGM Pharma
8.2.1 LGM Pharma Profile
8.2.2 LGM Pharma Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 LGM Pharma Product/Solution Launches and Enhancements Analysis
8.2.4 LGM Pharma Business Overview/Recent Development/Acquisitions
8.3 AstraZeneca
8.3.1 AstraZeneca Profile
8.3.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
8.3.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.4 Eli Lilly
8.4.1 Eli Lilly Profile
8.4.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Eli Lilly Product/Solution Launches and Enhancements Analysis
8.4.4 Eli Lilly Business Overview/Recent Development/Acquisitions
8.5 Boehringer Ingelheim Pharmaceuticals, Inc.
8.5.1 Boehringer Ingelheim Pharmaceuticals, Inc. Profile
8.5.2 Boehringer Ingelheim Pharmaceuticals, Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Boehringer Ingelheim Pharmaceuticals, Inc. Product/Solution Launches and Enhancements Analysis
8.5.4 Boehringer Ingelheim Pharmaceuticals, Inc. Business Overview/Recent Development/Acquisitions
8.6 Novartis International AG
8.6.1 Novartis International AG Profile
8.6.2 Novartis International AG Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Novartis International AG Product/Solution Launches and Enhancements Analysis
8.6.4 Novartis International AG Business Overview/Recent Development/Acquisitions
9 Global Gliptin Market-Segmentation by Geography
10 North America
10.1 North America Gliptin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Gliptin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Gliptin Production Analysis from 2015-2020
10.4 North America Gliptin Consumption Analysis from 2015-2020
10.5 North America Gliptin Import and Export from 2015-2020
10.6 North America Gliptin Value, Production and Market Share by Type (2015-2020)
10.7 North America Gliptin Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Gliptin by Country (United States, Canada)
10.8.1 North America Gliptin Sales by Country (2015-2020)
10.8.2 North America Gliptin Consumption Value by Country (2015-2020)
10.9 North America Gliptin Market PEST Analysis
11 Europe
11.1 Europe Gliptin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Gliptin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Gliptin Production Analysis from 2015-2020
11.4 Europe Gliptin Consumption Analysis from 2015-2020
11.5 Europe Gliptin Import and Export from 2015-2020
11.6 Europe Gliptin Value, Production and Market Share by Type (2015-2020)
11.7 Europe Gliptin Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Gliptin by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Gliptin Sales by Country (2015-2020)
11.8.2 Europe Gliptin Consumption Value by Country (2015-2020)
11.9 Europe Gliptin Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Gliptin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Gliptin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Gliptin Production Analysis from 2015-2020
12.4 Asia-Pacific Gliptin Consumption Analysis from 2015-2020
12.5 Asia-Pacific Gliptin Import and Export from 2015-2020
12.6 Asia-Pacific Gliptin Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Gliptin Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Gliptin by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Gliptin Sales by Country (2015-2020)
12.8.2 Asia-Pacific Gliptin Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Gliptin Market PEST Analysis
13 Latin America
13.1 Latin America Gliptin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Gliptin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Gliptin Production Analysis from 2015-2020
13.4 Latin America Gliptin Consumption Analysis from 2015-2020
13.5 Latin America Gliptin Import and Export from 2015-2020
13.6 Latin America Gliptin Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Gliptin Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Gliptin by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Gliptin Sales by Country (2015-2020)
13.8.2 Latin America Gliptin Consumption Value by Country (2015-2020)
13.9 Latin America Gliptin Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Gliptin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Gliptin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Gliptin Production Analysis from 2015-2020
14.4 Middle East & Africa Gliptin Consumption Analysis from 2015-2020
14.5 Middle East & Africa Gliptin Import and Export from 2015-2020
14.6 Middle East & Africa Gliptin Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Gliptin Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Gliptin by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Gliptin Sales by Country (2015-2020)
14.8.2 Middle East & Africa Gliptin Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Gliptin Market PEST Analysis
15 Future Forecast of the Global Gliptin Market from 2020-2028
15.1 Future Forecast of the Global Gliptin Market from 2020-2028 Segment by Region
15.2 Global Gliptin Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Gliptin Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
